Evaluation of the Role of Serum Midkine (MK) as A New Non-invasive Diagnostic Biomarker for Hepatocellular Carcinoma in Egyptian Cirrhotic Patients
(2025). Evaluation of the Role of Serum Midkine (MK) as A New Non-invasive Diagnostic Biomarker for Hepatocellular Carcinoma in Egyptian Cirrhotic Patients. EKB Journal Management System, 99(1), 2416-2423. doi: 10.21608/ejhm.2025.435009
. "Evaluation of the Role of Serum Midkine (MK) as A New Non-invasive Diagnostic Biomarker for Hepatocellular Carcinoma in Egyptian Cirrhotic Patients". EKB Journal Management System, 99, 1, 2025, 2416-2423. doi: 10.21608/ejhm.2025.435009
(2025). 'Evaluation of the Role of Serum Midkine (MK) as A New Non-invasive Diagnostic Biomarker for Hepatocellular Carcinoma in Egyptian Cirrhotic Patients', EKB Journal Management System, 99(1), pp. 2416-2423. doi: 10.21608/ejhm.2025.435009
Evaluation of the Role of Serum Midkine (MK) as A New Non-invasive Diagnostic Biomarker for Hepatocellular Carcinoma in Egyptian Cirrhotic Patients. EKB Journal Management System, 2025; 99(1): 2416-2423. doi: 10.21608/ejhm.2025.435009